With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and services in the United States and internationally. It operates through two ...

Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide in the long run.

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

COCA.xyz, the next-generation non-custodial payments app, has successfully completed a strategic funding round led by the Stellar Development Foundation (SDF), with participation from FunFair Ventures ...

At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will discuss ...

Investor Day to be held in New York on March 19 at 9 am. Webcast LinkLight Up your Portfolio with Spark:Easily identify stocks' risks and ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...

“We’d be able to check your health through a bunch of diagnostics, allow you to set your health goals and your budgets ... Tastemade previously raised $130 million from investors, closing its most ...

It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of ...